{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:12:43Z","timestamp":1762866763527,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.eimce.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:11:08Z","timestamp":1650931868000},"page":"276-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tachycardia as an undescribed adverse effect to the Comirnaty\u00a9 vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease"],"prefix":"10.1016","volume":"40","author":[{"given":"M. Teresa","family":"Marco Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Torres Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Berta","family":"Anta Agudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. de la Trinidad","family":"Rufino Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2022.03.002_bib0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"27","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"unstructured":"Informe sobre la situaci\u00f3n de COVID-19 en personal sanitario en Espa\u00f1a a 21 de mayo de 2020. Equipo COVID-19. RENAVE. CNE. CNM (ISCIII), [Accessed 25 January 2021]. Available from: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/INFORMES\/Informes%20COVID-19\/COVID-19%20en%20Espa%C3%B1a.%20Situaci%C3%B3n%20en%20Sanitarios%20a%2021%20de%20mayo%20de%202020.pdf.","key":"10.1016\/j.eimce.2022.03.002_bib0010"},{"unstructured":"Ficha T\u00e9cnica Comirnaty concentrado para dispersi\u00f3n inyectable, [Accessed 22 January 2021]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1201528001\/FT_1201528001.html.","key":"10.1016\/j.eimce.2022.03.002_bib0015"},{"unstructured":"1.\u00ba Informe de Farmacovigilancia sobre vacunas COVID-19 (25-01-2021). Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios, [Accessed 26 January 2021]. Available from: https:\/\/www.aemps.gob.es\/la-aemps\/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119\/vacunas-contra-la-covid%E2%80%9119\/1o-informe-de-farmacovigilancia-sobre-vacunas-covid-19-25-01-2021\/.","key":"10.1016\/j.eimce.2022.03.002_bib0020"},{"unstructured":"Nota Informativa vacuna en individuos que ya han pasado la enfermedad. Sociedad Espa\u00f1ola de Inmunolog\u00eda, [Accessed 22 January 2021]. Available from: https:\/\/www.inmunologia.org.","key":"10.1016\/j.eimce.2022.03.002_bib0025"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:59:50Z","timestamp":1762865990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X22000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2529993X22000417"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2022.03.002","relation":{},"ISSN":["2529-993X"],"issn-type":[{"type":"print","value":"2529-993X"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tachycardia as an undescribed adverse effect to the Comirnaty\u00a9 vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}]}}